We aimed to study how morphine affects synaptic transmission in the dentate gyrus and CA1 regions along the hippocampal long axis. For this, recording and measuring of field excitatory postsynaptic potentials (fEPSPs) were utilized to test the effects of repeated morphine exposure on paired-pulse evoked responses and long-term potentiation (LTP) at Schaffer collateral-CA1 (Sch-CA1), temporoammonic-CA1 (TA-CA1) and perforant pathway-dentate gyrus (PP-DG) synapses in transverse slices from the dorsal (DH), intermediate (IH), and ventral (VH) hippocampus in adult male rats. After repeated morphine exposure, the expression of opioid receptors and the α1 and α5 GABA subunits were also examined. We found that repeated morphine exposure blunt the difference between the DH and the VH in their basal levels of synaptic transmission at Sch-CA1 synapses that were seen in the control groups. Significant paired-pulse facilitation of excitatory synaptic transmission was observed at Sch-CA1 synapses in slices taken from all three hippocampal segments as well as at PP-DG synapses in slices taken from the VH segment in the morphine-treated groups as compared to the control groups. Interestingly, significant paired-pulse inhibition of excitatory synaptic transmission was observed at TA-CA1 synapses in the DH slices from the morphine-treated group as compared to the control group. While primed-burst stimulation (a protocol reflecting normal neuronal firing) induced a robust LTP in hippocampal subfields in all control groups, resulting in a decaying LTP at TA-CA1 synapses in the VH slices and at PP-DG synapses in both the IH and VH slices taken from the morphine-treated rats. In the DH of morphine-treated rats, we found increased levels of the mRNAs encoding the α1 and α5 GABA subunits as compared to the control group. Taken together, these findings suggest the potential mechanisms through which repeated morphine exposure causes differential changes in circuit excitability and synaptic plasticity in the dentate gyrus and CA1 regions along the hippocampal long axis.

Download full-text PDF

Source
http://dx.doi.org/10.1002/hipo.23488DOI Listing

Publication Analysis

Top Keywords

repeated morphine
20
morphine exposure
20
synapses slices
20
synaptic transmission
16
pp-dg synapses
12
control groups
12
compared control
12
synaptic plasticity
8
schaffer collateral-ca1
8
perforant pathway-dentate
8

Similar Publications

Opioid use disorder is a public health problem that includes symptoms such as withdrawal syndrome and opioid-induced hyperalgesia. Currently, drugs to treat side effects of opioids also have undesirable effects, which lead to limitations. This study investigated the effect of a treatment with cannabidiol in morphine-induced hyperalgesia and withdrawal behavior in morphine-dependent rats.

View Article and Find Full Text PDF
Article Synopsis
  • Adolescent exposure to THC (tetrahydrocannabinol) alters how morphine affects behavior in adulthood, impacting anxiety and drug-related responses.
  • * In particular, THC exposure reduced anxiety during morphine withdrawal but increased the craving for morphine, indicating complex interactions between these substances.
  • * Finally, the study identified changes in brain connectivity, particularly between the frontal cortex and dopamine regions, suggesting a neurological basis for how early THC exposure influences future responses to morphine.
View Article and Find Full Text PDF

The cannabinoid CB agonist LY2828360 suppresses neuropathic pain behavior and attenuates morphine tolerance and conditioned place preference in rats.

Neuropharmacology

December 2024

Program in Neuroscience, Indiana University, Bloomington, IN, USA; Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA; Gill Institute for Neuroscience, Indiana University, Bloomington, IN, USA. Electronic address:

Cannabinoid CB agonists show promise as analgesics because they lack unwanted side effects associated with direct activation of CB receptors. CB receptor activation suppresses pathological pain in animal models, but the types of pain that best respond to CB agonists are incompletely understood. This gap in knowledge may contribute to failures in clinical translation.

View Article and Find Full Text PDF

Examining the Severity and Progression of Illicitly Manufactured Fentanyl Withdrawal: A Quasi-Experimental Comparison.

J Addict Med

November 2024

From the Johns Hopkins School of Medicine, Behavioral Pharmacology Research Unit, Baltimore, MD (AS, KED, KS-D, SD, NK, ECS, CB); and Friends Research Institute Baltimore, MD, (AS).

Objective: Illicitly manufactured fentanyl has largely replaced heroin throughout the United States. Characteristics of fentanyl-specific withdrawal are not well understood compared to traditional opioid withdrawal. This study examines opioid withdrawal severity among 2 cohorts of study participants who underwent identical morphine stabilization procedures before and after fentanyl was introduced to the local drug market.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of astaxanthin on nociceptive transmission in a mouse model of painful diabetic neuropathy, aiming to assess its potential as a treatment option.
  • Researchers conducted tests with astaxanthin administered through different methods and doses, finding that it effectively reduces hypersensitivity in both male and female mice.
  • The results suggest that astaxanthin not only provides significant analgesic effects on its own but also may enhance pain relief when used with morphine, highlighting its promise for future clinical applications in diabetic neuropathy treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!